M
$ Value
—
Shares
1,246
Price
—
Filed
Mar 12
Insider
Name
Cain Wettan Keeley M
Title
EVP Gen Counsel, Legal & Comp
CIK
0002110603
Roles
Officer
Transaction Details
Transaction Date
2026-03-10
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
5,660
Footnotes
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. | The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Filing Info
Cain Wettan Keeley M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | GILD | M | — |
| 2026-03-10 | GILD | F | $90K |
| 2026-03-10 | GILD | M | — |
| 2026-03-10 | GILD | A | — |
| 2026-03-10 | GILD | A | $0 |
| 2026-02-27 | GILD | A | $0 |
Other Insiders at GILD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dickinson Andrew D
Chief Financial Officer
|
— | $463K | 2026-03-10 |
|
Dickinson Andrew D / Mercier Johanna
Chief Financial Officer
|
— | $856K | 2026-04-15 |
|
O'Day Daniel Patrick
Chairman & CEO
|
— | $21.6M | 2026-03-27 |
|
Berger Dietmar
Chief Medical Officer
|
— | — | 2026-03-10 |
|
Mercier Johanna
Chief Comm & Corp Aff Officer
|
— | $4.3M | 2026-03-10 |
|
Burkhart Erin
SVP, Controllership
|
— | — | 2026-03-10 |
|
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
|
— | — | 2026-03-10 |